Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis, Danube University Krems, Krems, Austria.
Department for Biomedical Research, Center for Biomedical Technology, Danube University Krems, Krems, Austria.
Mediators Inflamm. 2021 Mar 17;2021:8395048. doi: 10.1155/2021/8395048. eCollection 2021.
The timely recognition of sepsis and the prediction of its clinical course are challenging due to the complex molecular mechanisms leading to organ failure and to the heterogeneity of sepsis patients. Treatment strategies relying on a "one-fits-all" approach have failed to reduce mortality, suggesting that therapeutic targets differ between patient subgroups and highlighting the need for accurate analysis of the molecular cascades to assess the highly variable host response. Here, we characterized a panel of 44 inflammatory mediators, including cytokines, chemokines, damage-associated molecular patterns, and coagulation-related factors, as well as markers of endothelial activation in 30 patients suffering from renal failure in the course of sepsis. All patients received continuous veno-venous hemodialysis with either high cut-off filters or with standard filters, and mediators were quantified for all patients at the initiation of dialysis and after 24 h and 48 h. Mediator concentrations in individual patients ranged widely, demonstrating the heterogeneity of sepsis patients. None of the mediators correlated with SAPS III or TISS scores. The overall in-hospital mortality of the study population was 56.7% (57.1% 56.3% for high cut-off standard filter). The two filter groups differed regarding most of the mediator levels at baseline, prohibiting conclusions regarding the effect of standard filters high cut-off filters on mediator depletion. The elevation and correlation of damage-associated molecular patterns and markers of endothelial activation gave evidence of severe tissue damage. In particular, extracellular histones were strongly increased and were almost 30-fold higher in nonsurvivors as compared to survivors, indicating their diagnostic and prognostic potential.
由于导致器官衰竭的复杂分子机制以及脓毒症患者的异质性,及时识别脓毒症及其临床病程预测具有挑战性。依赖于“一刀切”方法的治疗策略未能降低死亡率,这表明治疗靶点在患者亚组之间存在差异,突出了需要准确分析分子级联反应,以评估宿主反应的高度可变性。在这里,我们在 30 名脓毒症合并肾衰竭患者中,鉴定了包括细胞因子、趋化因子、损伤相关分子模式和凝血相关因子以及内皮激活标志物在内的 44 种炎症介质的特征。所有患者均接受持续静脉-静脉血液透析,使用高截留过滤器或标准过滤器,在开始透析时以及透析 24 和 48 小时后对所有患者定量测定介质。个体患者的介质浓度差异很大,表明脓毒症患者存在异质性。没有一种介质与 SAPS III 或 TISS 评分相关。研究人群的总住院死亡率为 56.7%(高截留 标准过滤器为 57.1% 56.3%)。两组患者在基线时的大多数介质水平存在差异,因此无法得出关于标准过滤器 高截留过滤器对介质耗竭影响的结论。损伤相关分子模式和内皮激活标志物的升高和相关性表明存在严重的组织损伤。特别是细胞外组蛋白明显升高,非幸存者几乎是幸存者的 30 倍,表明其具有诊断和预后潜力。